SMMT241227P19000
- 1.50
- 0.000.00%
Summit Therapeutics Newsroom
Why Did Summit Therapeutics Inc. (SMMT) Jump Yesterday?
Where Will Summit Therapeutics Be in 5 Years?
Summit Therapeutics Shares Are Trading Higher. The Stock May Be Moving in Sympathy With Neurocrine Biosciences Which Received FDA Approval for CRESNESSITY.
Watching Summit Therapeutics; Traders Circulate Newsletter Mention
How Is The Market Feeling About Summit Therapeutics?
Summit Therapeutics Initiated at Overweight by Wells Fargo
Wells Fargo Initiates Summit Therapeutics(SMMT.US) With Buy Rating, Announces Target Price $30
Why Summit Therapeutics Stock Rocketed 6% Higher on Friday
Jefferies Initiates Summit Therapeutics(SMMT.US) With Buy Rating, Announces Target Price $31
Summit Expands Workers' Compensation Coverage to Illinois
Is Summit Therapeutics (NASDAQ:SMMT) Using Debt In A Risky Way?
Express News | Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
U.S. Stock Market Nuggets | Will the "cryptos czar" appear? MSTR's market cap surpasses the trillion-dollar mark, soaring 650% this year; excellent stocks are having a blast! Home retail giant WSM skyrockets over 27% overnight.
Included in the S&P MidCap 400 Index! Global manufacturing giant Flex Ltd. surged nearly 80% this year, with overnight stock prices hitting a new high.
Trump Media Saw the Largest Increase in Short Interest in October
Summit Therapeutics (SMMT) Hurt Bronte Capital. Here's Why
H.C. Wainwright Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Maintains Target Price $44
HC Wainwright & Co. Reiterates Buy on Summit Therapeutics, Maintains $44 Price Target
Strategic Position and Acquisition Interest Bolster Buy Rating for Summit Therapeutics
BNTX to Boost Oncology Pipeline With Biotheus Acquisition, Stock Up